Zhifei Longcom News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zhifei longcom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zhifei Longcom Today - Breaking & Trending Today

WHO authorises new Covid-19 vaccine

WHO authorised a new Covid-19 vaccine 'Convidecia' by a Chinese manufacturer CanSinoBIO as the country battles resurgence of Omicron variant ....

Shifa Pharmed , Zhifei Longcom , World Health Organization On , World Health Organization , Bharat Biotech ,

WHO authorizes China's CanSinoBIO COVID-19 vaccine

The WHO granted emergency use listing authorization to the single-shot Convidecia vaccine as China battles a resurgence of the virus triggered by the Omicron variant. ....

Shifa Pharmed , Zhifei Longcom , World Health Organization On , World Health Organization , Bharat Biotech , Covid 19 Vaccines ,

WHO authorises China's CanSinoBIO Covid-19 vaccine

WHO authorises China's CanSinoBIO Covid-19 vaccine
mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.

Shifa Pharmed , Zhifei Longcom , World Health Organization On , World Health Organization , Bharat Biotech ,

COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status | Infectious Diseases of Poverty

Safety data reported from the large-scale clinical trials of the coronavirus disease 2019 (COVID-19) vaccine are extremely limited in patients with decompensated cirrhosis. The vaccination campaign in this specific population could be difficult due to uncertainty about the adverse events following vaccination. We aimed to assessed the COVID-19 vaccination rate, factors associated with unvaccinated status, and the adverse events following vaccination in patients with decompensated cirrhosis. This is a retrospective study from Ruijin Hospial (Shanghai, China) on an ongoing prospective cohort designed for long-term survival analysis of decompensated cirrhotic patients who recovered from decompensating events or acute-on-chronic liver failure (ACLF) between 2016 and 2018. We assessed the COVID-19 vaccination rate, the number of doses, type of vaccine, safety data, patient-reported reasons for remaining unvaccinated, factors associated with unvaccinated status, and the adverse events of COV ....

Zhifei Longcom , Ruijin Hospital , Novel Coronavirus Vaccine ,